Literature DB >> 25157121

Elevation of serum B-cell activating factor levels during visceral leishmaniasis.

Yasuyuki Goto1, Satoko Omachi2, Chizu Sanjoba2, Yoshitsugu Matsumoto2.   

Abstract

Elevation of serum B-cell activating factor (BAFF) is one of the characteristics of immunological disorders, including autoimmunity, but the levels of BAFF in infectious diseases have not been studied well. Here, we showed the elevation of serum BAFF in patients with visceral leishmaniasis (VL). The mean serum BAFF value in VL patients (4.65 ng/mL) was 4.3 times higher than that of healthy controls (1.08 ng/mL), and 90% of VL patients showed serum BAFF above the cutoff that was calculated as the mean + 3 SDs of the controls. This report is the first on elevation of serum BAFF during VL. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25157121      PMCID: PMC4228886          DOI: 10.4269/ajtmh.14-0260

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

1.  BLyS and BLyS receptor expression in non-Hodgkin's lymphoma.

Authors:  Javier Briones; John M Timmerman; David M Hilbert; Ronald Levy
Journal:  Exp Hematol       Date:  2002-02       Impact factor: 3.084

2.  Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.

Authors:  Joanna Groom; Susan L Kalled; Anne H Cutler; Carl Olson; Stephen A Woodcock; Pascal Schneider; Jurg Tschopp; Teresa G Cachero; Marcel Batten; Julie Wheway; Davide Mauri; Dana Cavill; Tom P Gordon; Charles R Mackay; Fabienne Mackay
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

3.  Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.

Authors:  Takashi Matsushita; Minoru Hasegawa; Koichi Yanaba; Masanari Kodera; Kazuhiko Takehara; Shinichi Sato
Journal:  Arthritis Rheum       Date:  2006-01

4.  Interleukin 10 production correlates with pathology in human Leishmania donovani infections.

Authors:  H W Ghalib; M R Piuvezam; Y A Skeiky; M Siddig; F A Hashim; A M el-Hassan; D M Russo; S G Reed
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis.

Authors:  J P Haldar; S Ghose; K C Saha; A C Ghose
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

6.  Serological investigations on Indian kala-azar.

Authors:  A C Ghose; J P Haldar; S C Pal; B P Mishra; K K Mishra
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

7.  Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.

Authors:  E M Carvalho; R Badaró; S G Reed; T C Jones; W D Johnson
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

8.  BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection.

Authors:  Anja Scholzen; Anne C Teirlinck; Else M Bijker; Meta Roestenberg; Cornelus C Hermsen; Stephen L Hoffman; Robert W Sauerwein
Journal:  J Immunol       Date:  2014-03-19       Impact factor: 5.422

9.  Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.

Authors:  F Mackay; S A Woodcock; P Lawton; C Ambrose; M Baetscher; P Schneider; J Tschopp; J L Browning
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

10.  A role for IgG immune complexes during infection with the intracellular pathogen Leishmania.

Authors:  Suzanne A Miles; Sean M Conrad; Renata G Alves; Selma M B Jeronimo; David M Mosser
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

View more
  7 in total

Review 1.  The Role of BAFF System Molecules in Host Response to Pathogens.

Authors:  Jiro Sakai; Mustafa Akkoyunlu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

2.  Disruption of Splenic Lymphoid Tissue and Plasmacytosis in Canine Visceral Leishmaniasis: Changes in Homing and Survival of Plasma Cells.

Authors:  Joselli Silva-O'Hare; Isabela Silva de Oliveira; Thaís Klevorn; Valter A Almeida; Geraldo G S Oliveira; Ajax M Atta; Luiz Antonio R de Freitas; Washington L C Dos-Santos
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

3.  Correlation of APRIL with production of inflammatory cytokines during acute malaria in the Brazilian Amazon.

Authors:  Raquel A Pinna; Adriana C Dos Santos; Daiana S Perce-da-Silva; Luciene A da Silva; Rodrigo N Rodrigues da Silva; Marcelo R Alves; Fátima Santos; Joseli de Oliveira Ferreira; Josué C Lima-Junior; Déa M Villa-Verde; Paula M De Luca; Carla E Carvalho-Pinto; Dalma M Banic
Journal:  Immun Inflamm Dis       Date:  2018-01-03

4.  Cytokines and splenic remodelling during Leishmania donovani infection.

Authors:  Marcela Montes de Oca; Christian R Engwerda; Paul M Kaye
Journal:  Cytokine X       Date:  2020-09-01

Review 5.  Histological Disorganization of Spleen Compartments and Severe Visceral Leishmaniasis.

Authors:  Micely d'El-Rei Hermida; Caroline Vilas Boas de Melo; Isadora Dos Santos Lima; Geraldo Gileno de Sá Oliveira; Washington L C Dos-Santos
Journal:  Front Cell Infect Microbiol       Date:  2018-11-13       Impact factor: 5.293

6.  Leishmania infantum recombinant kinesin degenerated derived repeat (rKDDR): A novel potential antigen for serodiagnosis of visceral leishmaniasis.

Authors:  Lucas Dhom-Lemos; Agostinho Gonçalves Viana; João Luis Reis Cunha; Mariana Santos Cardoso; Tiago Antônio Oliveira Mendes; Guilherme Rafael Gomide Pinheiro; Williane Fernanda Siqueira; Francisco Pereira Lobo; Leandro Freitas Teles; Lilian Lacerda Bueno; Silvio Fernando Guimarães-Carvalho; Daniella Castanheira Bartholomeu; Ricardo Toshio Fujiwara
Journal:  PLoS One       Date:  2019-01-31       Impact factor: 3.240

7.  Anti-Leishmania infantum Antibody-Producing Plasma Cells in the Spleen in Canine Visceral Leishmaniasis.

Authors:  Jonathan L M Fontes; Bianca R Mesquita; Reginaldo Brito; Juliana C S Gomes; Caroline V B de Melo; Washington L C Dos Santos
Journal:  Pathogens       Date:  2021-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.